Skip to main content

Table 2 Key characteristics of individuals with suboptimal or no mood stabilizer treatment

From: Is cognitive behaviour therapy applicable to individuals diagnosed with bipolar depression or suboptimal mood stabilizer treatment: a secondary analysis of a large pragmatic effectiveness trial

  TAU (n = 20) CBT (n = 19)
Mean age (SD) 43.1 (10.97) 41. 21 (11.3)
Female 14 (70%) 14 (74%)
Current comorbid mental disorder 6 (30%) 10 (53%)
Current substance misuse 2 (10%) 1 (5%)
Median HRSD score (IQR) 6 (3, 9) 7 (3, 10)
Median BRMS score (IQR) 2 (0, 3) 2, (1, 3)
Median number of episodes:
Major depression (IQR) 3.8 (1–9) 4 (1–10)
Mania/hypomania/mixed (IQR) 3 (2–6) 2.9 (2–6)
Current medication
 None 2 (10%) 1 (5%)
 Benzodiazepine monotherapy 0 1 (5%)
 Anti-depressant monotherapy 6 (30%) 5 (26%)
Other medication 2 (10%) 4 (21%)
Current adherence level < 50% 11 (55%) 11 (58%)
  1. Adherence level measured using the tablet routines questionnaire
  2. SD standard deviation, IQR inter-quartile range